India, June 23 -- The article outlines the importance of the deal for this pharma company, which operates in over 150 countries, specializing in generic drugs, active pharmaceutical ingredients, and injectables across therapeutic areas like antibiotics, CVS, CNS, and anti-retrovirals

With a market capitalization of Rs 87,817 crore, Aurobindo Pharma Ltd's shares currently trade at Rs 1,512 per share, up 1.32 percent from the previous day's close. The company's share gave a return of 60.5 percent over the last five years.

Key Highlights of the Deal Aurobindo Pharma's wholly owned subsidiary, Aurobindo Pharma USA, has received approval from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC for $...